CME / CE

What's Your Role? Exploring the Value of the Entire Healthcare Team in Nonmelanoma Skin Cancer Care

Authors: Theresa S. Brown, PharmD, BCOP, CPP; Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN-BC; Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R; Michael R. Migden, MD; Vishal A. Patel, MD; Michael K. Wong, MD, PhD
CME / CE Released: 9/29/2023
Valid for credit through: 9/29/2024, 11:59 PM EST

Credits Available

Physicians - maximum of 0.75 AMA PRA Category 1 Credit(s)™

Nurses - 0.75 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

Pharmacists - 0.75 Knowledge-based ACPE (0.075 CEUs)

IPCE - 0.75 Interprofessional Continuing Education (IPCE) credit

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for oncologists; dermatologists, including Mohs surgeons; surgeons, including head and neck (H&N) surgeons; oncology nurses and nurse practitioners (NPs); oncology pharmacists; and other members of the skin cancer care team.

The goal of this activity is for learners to be better able to recognize the value of multidisciplinary and interprofessional team members in the comprehensive care of patients receiving immunotherapy for the treatment of NMSCs.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Role of the multidisciplinary team (MDT) in the comprehensive care of patients receiving immunotherapy for NMSC
- Resources available to help patients navigate through the care journey for NMSC
Have greater competence related to
- Accurately diagnosing NMSC
- Selecting the optimal immunotherapy-containing regimen for a patient with NMSC
- Mitigating potential treatment-related adverse events in patients receiving therapy for NMSC
- Communicating treatment considerations to patients with NMSC

Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Faculty

Theresa S. Brown, PharmD, BCOP, CPP

Clinical Oncology Pharmacist - Melanoma and Sarcoma
Duke University Hospital
Durham, North Carolina

Disclosures

Theresa S. Brown, PharmD, BCOP, CPP, has the following relevant financial relationships:
Speaker or member of speakers bureau for: Regeneron Pharmaceuticals, Inc.

Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN-BC

Nurse Practitioner
Melanoma Program
New York University Health
NYU Langone Perlmutter Cancer Center
New York, New York

Disclosures

Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN-BC, has no relevant financial relationships.

Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R

Senior Director of Education and Training
CancerCare
New York, New York

Disclosures

Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R, has no relevant financial relationships.

Michael R. Migden, MD

Professor of Dermatology
Division of Internal Medicine
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Disclosures

Michael R. Migden, MD, has the following relevant financial relationships:
Consultant or advisor for: Regeneron Pharmaceuticals, Inc.; Replimune; Stamford Pharmaceuticals; Sun Pharmaceuticals Industries, Ltd.
Research funding from: Regeneron Pharmaceuticals, Inc.; Replimune; Senhwa

Vishal A. Patel, MD

Director of Dermatologic Surgery
Director of Cutaneous Oncology
Associate Professor of Dermatology
and Medicine, Oncology
George Washington School of Medicine
and Health Sciences
Washington, DC

Disclosures

Vishal A. Patel, MD, has the following relevant financial relationships:
Consultant or advisor for: Almirall; InflaRx; Jounce Therapeutics; Palvella; PhD Biosciences; Regeneron Pharmaceuticals, Inc.; Sanofi
Speaker or member of speakers bureau for: Regeneron Pharmaceuticals, Inc.
Research funding from: Regeneron Pharmaceuticals, Inc.
Contracted researcher for: Regeneron Pharmaceuticals, Inc.
Stock options from: Avstera; Lazarus AI
Owns stock (publicly traded) in: Science 37, Inc.

Michael K. Wong, MD, PhD

Professor of Melanoma Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

Disclosures

Michael K. Wong, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Bristol Myers Squibb; Castle Biosciences; EMD-Serono; ExiCure; Merck; Pfizer, Inc.; Regeneron Pharmaceuticals, Inc.; Replimune

Editors

Deborah Middleton, MS

Senior Medical Education Director, WebMD Global, LLC

Disclosures

Deborah Middleton, MS, has no relevant financial relationships.

Yoji Yamaguchi, MA, ELS

Scientific Content Manager, Medscape, LLC

Disclosures

Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

Contact This Provider

For Nurses

Awarded 0.75 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

Contact This Provider

For Pharmacists

Medscape designates this continuing education activity for 0.75 contact hour(s) (0.075 CEUs) (Universal Activity Number: JA0007105-0000-23-352-H01-P).

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Oncology

CME / CE

What's Your Role? Exploring the Value of the Entire Healthcare Team in Nonmelanoma Skin Cancer Care

Authors: Theresa S. Brown, PharmD, BCOP, CPP; Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN-BC; Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R; Michael R. Migden, MD; Vishal A. Patel, MD; Michael K. Wong, MD, PhDFaculty and Disclosures

CME / CE Released: 9/29/2023

Valid for credit through: 9/29/2024, 11:59 PM EST

processing....

Select Any Chapter to Begin

Page 1 of 25

The Role of the Dermatologist in the Management of Advanced Nonmelanoma Skin Cancer - Pre-Assessment

Earn Credit CME / CE Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Theresa S. Brown, PharmD, BCOP, CPP

Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN-BC

Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R

Michael R. Migden, MD

Vishal A. Patel, MD

Michael K. Wong, MD, PhD

Editors

Deborah Middleton, MS

Yoji Yamaguchi, MA, ELS

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

CME / CE

What's Your Role? Exploring the Value of the Entire Healthcare Team in Nonmelanoma Skin Cancer Care

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Theresa S. Brown, PharmD, BCOP, CPP

Kathleen Madden, RN, MSN, FNP-BC, AOCNP, APHN-BC

Carolyn Messner, DSW, BCD, FNAP, FAPOS, FAOSW, LCSW-R

Michael R. Migden, MD

Vishal A. Patel, MD

Michael K. Wong, MD, PhD

Editors

Deborah Middleton, MS

Yoji Yamaguchi, MA, ELS

Compliance Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CNE, CHCP

Peer Reviewer

Accreditation Statements

For Physicians

For Nurses

For Pharmacists

Instructions for Participation and Credit

What's Your Role? Exploring the Value of the Entire Healthcare Team in Nonmelanoma Skin Cancer Care

Select Any Chapter to Begin